A comprehensive new study supports evidence of the myriad health benefits of GLP-1 medications like Ozempic and Mounjaro — ...
Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight ...
Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...
A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...
An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...
Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like drugs also appear to ...
It arrives at a time when anecdotal reports and small studies attesting to new effects of drugs sold under brand names such as Mounjaro, Ozempic, Wegovy and Zepbound emerge regularly.
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
I consulted a dietician and a psychologist to find out about this so-called “Ozempic personality.” Related: What Happens When You Take Ozempic for Weight Loss? An Endocrinologist, Aesthetic Medicine ...